Microsoft debuts an advanced diagnostic AI model, while major studies highlight both technical progress and patient trust concerns in medical AI.
Key Details
- 1Microsoft's MAI-DxO AI outperformed physicians on 85% of 304 NEJM real-world cases, reportedly quadrupling expert diagnostic rates.
- 2MIT and Mass General Brigham announced a new Analog Devices-funded program for joint medical AI research, aiming for six projects yearly.
- 3MIT researchers found LLMs may misdirect patients using colloquial symptom descriptions, with particular risk for female patients.
- 4A survey for ModMed found 55% of patients are uncomfortable with AI in diagnosis/treatment, yet 57% support it if it improves doctor-patient face time.
- 5New studies confirm patients perceive less empathy from AI-generated responses than from humans, impacting trust.
- 6Recent imaging AI highlights include tools for lung tumor segmentation, dementia diagnosis, and fatty liver detection via radiographs.
Why It Matters
Microsoft's LLM performance signals a leap in AI diagnostic accuracy and resource management, while the research on communication and trust underscores persistent challenges for clinical AI adoption. The breadth of new imaging AI applications and landmark academic partnerships indicate accelerating innovation but also highlight the need to address real-world usability and acceptance.
Source
AI in Healthcare
Related News
•AI in Healthcare
Literature Review Highlights Gaps in Economic Evaluation of Healthcare AI
A Finnish review finds significant gaps in economic evaluation reporting of AI technologies in Western healthcare.
•AI in Healthcare
Economic Evaluations of AI in Healthcare Face Major Gaps
A Finnish review finds significant deficiencies in how studies evaluate and report the economic impact of healthcare AI.
•Health Imaging
AI Platform Triples Functional Independence in UK Stroke Patients
AI brain imaging software deployed by NHS has significantly improved stroke outcomes and functional independence rates in England.